Submitted by Anonymous (not verified) on 5 October 2026 - 13:55
Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 15, Status: Authorised